{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-004677","form_type":"8-K","ticker":"ALHC","cik":"0001832466","company_name":"Alignment Healthcare, Inc.","filed_at":"2022-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.668266+00:00","generated_at":"2026-06-26T17:40:49.826216+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Alignment Healthcare President & CBO Rajesh Shrestha to depart April 1, 2022","bullets":["Rajesh Shrestha's employment as President, New Markets and CBO terminated effective April 1, 2022; no disagreement cited.","Severance includes acceleration of RSUs based on closing price, 2021 bonus of $504,846 (80% paid on effective date), and COBRA premium payments for 11 months.","All other unvested options and RSUs cancelled; sign-on and relocation bonuses not required to be repaid."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-004677","json":"https://secwatch.observer/filing/0000950170-22-004677.json","markdown":"https://secwatch.observer/filing/0000950170-22-004677.md","text":"https://secwatch.observer/filing/0000950170-22-004677.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832466/000095017022004677/0000950170-22-004677-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832466/000095017022004677/alhc-20220323.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T17:40:49.826216+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ef89a4fccb","claim":"Rajesh Shrestha was terminated as President, New Markets and Chief Business Officer at Alignment Healthcare, Inc..","evidence_excerpt":"mutually agreed to terminate his employment as President, New Markets and Chief Business Officer of the Company, effective as of April 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832466/000095017022004677/0000950170-22-004677-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"President, New Markets and Chief Business Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}